ICD-10 Coding for Systemic Lupus Erythematosus(F06.7U, M32.0, M32.0B)
Comprehensive guide to ICD-10 coding for systemic lupus erythematosus, including code relationships, documentation requirements, and clinical validation.
Complete code families applicable to Systemic Lupus Erythematosus
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| M32.0 | Drug-induced systemic lupus erythematosus | Use when SLE is directly linked to drug exposure. |
|
| M32.1 | Systemic lupus erythematosus with organ or system involvement | Use when SLE affects specific organs or systems. |
|
| M32.9 | Systemic lupus erythematosus, unspecified | Use when SLE is diagnosed but organ involvement is not specified. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutSystemic Lupus Erythematosus
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Systemic Lupus Erythematosus.
Documenting 'lupus' without specifying type
Impact
Clinical: Inadequate treatment planning, Regulatory: Non-compliance with coding standards, Financial: Potential reimbursement issues
Mitigation
Always specify 'systemic' or 'discoid' lupus, Use detailed clinical notes
Using M32.9 when organ involvement is documented
Impact
Reimbursement: Potential underpayment due to lack of specificity, Compliance: Non-compliance with coding guidelines, Data Quality: Inaccurate clinical data representation
Mitigation
Use M32.1 with additional codes for organ involvement.
Specificity of organ involvement
Impact
Failure to document specific organ involvement can lead to audit issues.
Mitigation
Ensure detailed documentation of organ-specific symptoms and diagnostic results.